Printed Drug-Delivery Systems for Improved Patient Treatment

Trends in Pharmacological Sciences

Volumn 37, Issue 12, 2016, Pages 1070-1080

  Sandler, Niklas ^a   Preis, Maren ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

3D printing; drug delivery systems; inkjet printing; personalized drugs

Indexed keywords

ACCURACY; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG MANUFACTURE; FOOD AND DRUG ADMINISTRATION; HUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY CONTROL; REVIEW; THREE DIMENSIONAL PRINTING; COMPUTER AIDED DESIGN; DRUG RELEASE; MEDICINAL CHEMISTRY; PHARMACEUTICS; PROCEDURES;

DRUG;

CHEMISTRY, PHARMACEUTICAL; COMPUTER-AIDED DESIGN; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG LIBERATION; HUMANS; PHARMACEUTICAL PREPARATIONS; PRECISION MEDICINE; PRINTING, THREE-DIMENSIONAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 84995922779     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2016.10.002     Document Type: Review

References (44)

1. 1 Breitkreutz, J., Boos, J., Paediatric and geriatric drug delivery. Expert Opin. Drug Deliv. 4 (2007), 37–45.
2. 2 Hamburg, M.A., Collins, F.S., The path to personalized medicine. N. Engl. J. Med. 363 (2010), 301–304.
3. 3 Collins, F.S., Varmus, H., A new initiative on precision medicine. N. Engl. J. Med. 372 (2015), 793–795.
4. 4 Jones, D., Steps on the road to personalized medicine. Nat. Rev. Drug. Discov. 6 (2007), 770–771.
5. 5 Bruno, B.J., et al. Basics and recent advances in peptide and protein drug delivery. Ther. Deliv. 4 (2013), 1443–1467.
6. 6 Rosenholm, J.M., et al. Mesoporous silica nanoparticles in tissue engineering: a perspective. Nanomedicine 11 (2016), 391–402.
7. 7 Jonathan, G., Karim, A., 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int. J Pharm. 499 (2016), 376–394.
8. 8 Forrest, S.R., The path to ubiquitous and low-cost organic electronic appliances on plastic. Nature 428 (2004), 911–918.
9. 9 de Gans, B.J., et al. Inkjet printing of polymers: state of the art and future developments. Adv. Mat. 16 (2004), 203–213.
10. 10 Sandler, N., et al. Inkjet printing of drug substances and use of porous substrates – towards individualized dosing. J. Pharm. Sci. 100 (2011), 3386–3395.
11. 11 Preis, M., et al. Perspective: concepts of printing technologies for oral film formulations. Int. J. Pharm. 494 (2015), 578–584.
12. 12 Shafiee, A., Atala, A., Printing technologies for medical applications. Trends Mol. Med. 22 (2016), 254–265.
13. 13 Chia, H.N., Wu, B.M., Recent advances in 3D printing of biomaterials. J. Biol. Eng., 9, 2014, 4.
14. 14 Kolakovic, R., et al. Printing technologies in fabrication of drug delivery systems. Expert Opin. Drug Deliv. 10 (2013), 1711–1723.
15. 15 Sandler, N., et al. Rapid interferometric imaging of printed drug laden multilayer structures. Sci. Rep., 7, 2014, 4020.
16. 16 Genina, N., et al. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques. Eur. J. Pharm. Sci. 47 (2012), 615–623.
17. 17 Alomari, M., et al. Personalised dosing: printing a dose of one's own medicine. Int. J. Pharm. 494 (2015), 568–577.
18. 18 Amstutz, U., Carleton, B.C., Pharmacogenetic testing: time for clinical practice guidelines. Clin. Pharmacol. Ther. 89 (2011), 924–927.
19. 19 Arya, A., et al. Fast dissolving oral films: an innovative drug delivery system and dosage forms. Int. J. Chem. Tech. Res. 2 (2010), 576–583.
20. 20 Becker, M.L., Leeder, J.S., Identifying genomic and developmental causes of adverse drug reactions in children. Pharmacogenomics 11 (2010), 1591–1602.
21. 21 Boparai, M.K., Korc Grodzicki, B., Prescribing for older adults. Mt. Sinai. J. Med. 78 (2011), 613–626.
22. 22 European Medicines Agency, Reflection Paper on Extrapolation of Efficacy and Safety in Paediatric Medicine Development (EMA/199678/2016). 2006, European Medicines Agency.
23. 23 van Riet-Nales, D.A., et al. The accuracy, precision and sustainability of different techniques for tablets subdivision: breaking by hand and the use of tablets splitters or a kitchen knife. Int. J. Pharm. 466 (2014), 44–51.
24. 24 Preis, M., Orally disintegrating films and mini-tablets – innovative dosage forms of choice for pediatric use. AAPS PharmSciTech 16 (2015), 234–241.
25. 25 Zajicek, A., et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 15 (2013), 1072–1081.
26. 26 Pardeike, J., et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int. J. Pharm. 420 (2011), 93–100.
27. 27 Khaled, S.A., et al. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 461 (2014), 105–111.
28. 28 Goyanes, A., et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 476 (2014), 88–92.
29. 29 Sandler, N., et al. Towards fabrication of 3D printed medical devices to prevent biofilm formation. Int. J. Pharm. 459 (2014), 62–64.
30. 30 Goyanes, A., et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 89 (2015), 157–162.
31. 31 Goyanes, A., et al. Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm. 494 (2015), 657–663.
32. 32 Water, J.J., et al. Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J. Pharm. Sci. 104 (2015), 1099–1107.
33. 33 Genina, N., et al. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur. J. Pharm. Sci. 90 (2015), 53–63.
34. 34 Holländer, J., et al. 3D printed PCL-based implantable prototypes of medical devices for controlled drug delivery. J. Pharm Sci. 105 (2016), 2665–2676.
35. 35 Buanz, A.B., et al. Preparation of personalized dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm. Res. 28 (2011), 2386–2392.
36. 36 Raijda, D., et al. Designing printable medicinal products: solvent system and carrier-substrate screening. Chem. Eng. Technol. 37 (2014), 1291–1296.
37. 37 Janßen, E.M., et al. Drug-printing by flexographic printing technology – a new manufacturing process for orodispersible films. Int. J. Pharm. 441 (2013), 818–825.
38. 38 Palo, M., et al. Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing N. Int. J. Pharm. 494 (2015), 603–610.
39. 39 Genina, N., et al. Evaluation of different substrates for inkjet printing of rasagiline mesylate. Eur. J. Pharm. Biopharm. 85 (2013), 1075–1083.
40. 40 Lee, B.K., et al. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int. J. Pharm. 427 (2012), 305–310.
41. 41 Goyanes, A., et al. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol. Pharm. 12 (2015), 4077–4084.
42. 42 Boetker, J., et al. Modifying release characteristics from 3D printed drug-eluting products. Eur. J. Pharm. Sci. 90 (2016), 47–52.
43. 43 Norman, J., et al. A new chapter in pharmaceutical manufacturing: 3D printed drugs. Adv. Drug Deliv. Rev., 2016, 10.1016/j.addr.2016.03.001 Published online March 18, 2016.
44. 44 Di Prima, M., et al. Additively manufactured medical products – the FDA perspective. 3D Print. Med., 2, 2016, 1.